These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1781711)

  • 1. [Chemotherapy of newborns with intestinal infections caused by opportunistic gram-negative aerobic bacteria].
    Litiaeva LA
    Antibiot Khimioter; 1991 Sep; 36(9):37-8. PubMed ID: 1781711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibiotic sensitivity of gram-negative opportunistic bacteria isolated from the feces of newborn infants with intestinal infections].
    Litiaeva LA; Zakopaeva ES
    Antibiot Khimioter; 1989 Jan; 34(1):66-8. PubMed ID: 2730219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunochemotherapy of infants in the first year of life with intestinal infections due to opportunistic gram-negative aerobic bacteria].
    Litiaeva LA
    Antibiot Khimioter; 1992 Oct; 37(10):44-6. PubMed ID: 1296536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.
    Lee SC; Huang SS; Lee CW; Fung CP; Lee N; Shieh WB; Siu LK
    BMC Infect Dis; 2007 Jul; 7():79. PubMed ID: 17640342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotic sensitivity of the main opportunistic pathogenic aerobic bacteria].
    Minukhin VV; Tsyganenko AIa; Kravtsova VI; Arkushenko LL; Stepanenko TV
    Antibiot Khimioter; 1990 Mar; 35(3):36-8. PubMed ID: 2113800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and in vitro activity of the ciprofloxacin-azlocillin combination (ratio 1:10) against gram-negative bacteria from non-neutropenic haematologic patients.
    Piccolomini R; Di Girolamo A; Iacone A; Fioritoni G; Cellini L; Nicoletti M; D'Antonio D
    Drugs Exp Clin Res; 1991; 17(9):455-60. PubMed ID: 1822439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial spectrum and antimicrobial susceptibility patterns in acquired and connatal lacrimal duct stenosis.
    Prokosch V; Prokosch JE; Promesberger J; Idelevich EA; Böhm MR; Thanos S; Stupp T
    Curr Eye Res; 2014 Nov; 39(11):1069-75. PubMed ID: 24912091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tigecycline: a novel glycylcycline antibiotic.
    Zhanel GG; Karlowsky JA; Rubinstein E; Hoban DJ
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):9-25. PubMed ID: 16441206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Outlook for using bacteria of the genus Bacillus for the design of new biopreparations].
    Sorokulova IB
    Antibiot Khimioter; 1996; 41(10):13-5. PubMed ID: 9027285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART).
    Chow JW; Satishchandran V; Snyder TA; Harvey CM; Friedland IR; Dinubile MJ
    Surg Infect (Larchmt); 2005; 6(4):439-48. PubMed ID: 16433608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer and neutropenia.
    Rolston KV
    Clin Infect Dis; 2005 Apr; 40 Suppl 4():S246-52. PubMed ID: 15768330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of reamberin for the treatment of acute intestinal infections caused by opportunistic bacteria].
    Frolov VM; Peresadin NA; Sotskaia IaA; Kruglova OV
    Klin Med (Mosk); 2013; 91(1):62-5. PubMed ID: 23659074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro study of the antibacterial effect of cefotetan against gram-positive and gram-negative aerobic and anaerobic strains from fresh clinical isolates.
    Klietmann W; Focht J; Nösner K
    Chemioterapia; 1987 Jun; 6(2 Suppl):92-3. PubMed ID: 3509542
    [No Abstract]   [Full Text] [Related]  

  • 14. [Aztreonam--new antibiotic for treating infections caused by gram-negative aerobic bacteria].
    Szymkowiak J; Fojt E
    Wiad Lek; 1993; 46(1-2):56-61. PubMed ID: 8249381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Necrotizing soft tissue infections: role of the localization for the antibiotic management].
    Wattel F; Mathieu D; Neut C; Dubreuil L; Cesari JF; Favory R
    Bull Acad Natl Med; 2004; 188(3):473-86; discussion 486-90. PubMed ID: 15584657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of anaerobic and aerobic bacteria isolated from patients with mixed infections in Nicaragua.
    Cáceres M; Carrera E; Palma A; Berrios G; Weintraub A; Nord CE
    Rev Esp Quimioter; 1999 Dec; 12(4):332-9. PubMed ID: 10855012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The study of drug resistance in aerobic and anaerobic bacterial flora to selected antibacterial drugs].
    Michalska W; Chylak J; Pietkiewicz K
    Med Dosw Mikrobiol; 1996; 48(1-2):61-70. PubMed ID: 8926770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriology and antibiotic susceptibility of community-acquired intra-abdominal infection in children.
    Lin WJ; Lo WT; Chu CC; Chu ML; Wang CC
    J Microbiol Immunol Infect; 2006 Jun; 39(3):249-54. PubMed ID: 16783457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic Gram-positive bacteria isolated from bacterial skin infections.
    Nenoff P; Haustein UF; Hittel N
    Chemotherapy; 2004 Oct; 50(4):196-201. PubMed ID: 15452398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerobic bacteria isolated from blood cultures of patients and their antibiotic susceptibilities in Harare, Zimbabwe.
    Obi CL; Mazarura E
    Cent Afr J Med; 1996 Dec; 42(12):332-6. PubMed ID: 9164012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.